| Insulin Glargine in Type 2 Diabetes Mellitus (NCT00311818) | Sanofi | 2003-06-01 |
| Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic Patients (NCT00123643) | St. Paul Heart Clinic | 2003-05-01 |
| Study of Multiple Doses of Saxagliptin (BMS-477118) (NCT00950599) | AstraZeneca | 2003-05-01 |
| Effects of Disease Management on Development of End Stage Renal Disease in Type 2 Diabetic Patients With Nephropathy (NCT00309127) | Chinese University of Hong Kong | 2003-05-01 |
| Olmesartan Medoxomil and Diabetic Nephropathy (NCT00362960) | Sankyo Pharma Gmbh | 2003-05-01 |
| Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus (NCT00108004) | AstraZeneca | 2003-04-01 |
| ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial (NCT00141453) | Daiichi Sankyo Co., Ltd. | 2003-04-01 |
| Molecular Mechanisms of Type 2 Diabetes Mellitus (NCT00816218) | The University of Texas Health Science Center at San Antonio | 2003-03-01 |
| Insulin Glargine Versus Twice-Daily NPH (NCT00687453) | Charles Drew University of Medicine and Science | 2003-02-01 |
| Insulin Glargine at Bedtime or in AM Versus NPH (NCT00686712) | Charles Drew University of Medicine and Science | 2003-02-01 |
| Effectiveness of PRECEDE Model for Health Education on Changes and Level of Control in Patients With Type 2 Diabetes Mellitus (NCT01316367) | Hospital Carlos III, Madrid | 2003-02-01 |
| Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Who Have Not Received Prior Treatment (NCT00330330) | Ionis Pharmaceuticals, Inc. | 2003-02-01 |
| South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes Mellitus (NCT00121966) | Odense University Hospital | 2003-01-01 |
| Insulin Resistance and Central Nervous System (CNS) Function in Type 2 Diabetes (NCT00212290) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2002-11-01 |
| Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes Mellitus (NCT00353691) | Sanofi | 2002-10-01 |
| Glucose Containing and Glucose Free Hemodialysate in Type 2 Diabetic Patients (NCT02009514) | Tampere University Hospital | 2002-10-01 |
| Extension Study for 2993-112 (NCT01789957) | AstraZeneca | 2002-09-01 |
| Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients (NCT00819325) | Queen Elizabeth II Health Sciences Centre | 2002-08-01 |
| Evaluation of Diabetes Self-Management Consultant Care (NCT00109720) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2002-08-01 |
| Efficacy of 2 Diet Plans Designed for People With Type II Diabetes on Weight and Health Measures (NCT00198757) | Johns Hopkins Bloomberg School of Public Health | 2002-07-01 |
| Long Term Free Living Study With Modified Foods and Type 2 Diabetics (NCT00198913) | Johns Hopkins Bloomberg School of Public Health | 2002-06-01 |
| Prospective Cohort Study of 4,837 Post-myocardial Infarction Patients (Alpha Omega Cohort) (NCT03192410) | Wageningen University | 2002-04-01 |
| Phielix et al.: Hepatic Fat Content and Adipokines (NCT01570660) | German Diabetes Center | 2002-02-01 |
| A 2 Year Trial of Patients With Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control (NCT00133718) | Asker & Baerum Hospital | 2002-01-01 |
| TRENDY Follow-up: Study on Endothelial Function in Subjects With Type 2 Diabetes Mellitus (NCT00905528) | University of Erlangen-Nürnberg Medical School | 2002-01-01 |
| TTA in Treatment of Diabetes and Dyslipidemia (NCT00605787) | Haukeland University Hospital | 2002-01-01 |
| Ginkgo Biloba Extract and the Insulin Resistance Syndrome (NCT00032474) | National Center for Complementary and Integrative Health (NCCIH) | 2001-12-01 |
| MK0767 in Type 2 Diabetes (0767-012) (NCT00543556) | Merck Sharp & Dohme LLC | 2001-10-01 |
| Glucose and Lipid Metabolism on Antipsychotic Medication (NCT00515723) | Washington University School of Medicine | 2001-09-01 |
| HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED) (NCT00480805) | Organon and Co | 2001-08-08 |
| Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin (NCT00036504) | Eli Lilly and Company | 2001-08-01 |
| Acute Effects of Sildenafil on Endothelial Function in People With Diabetes (NCT00527995) | Ruhr University of Bochum | 2001-08-01 |
| Atorvastatin and Endothelial Function in Type 2 Diabetes Mellitus (ATTEND-Study) (NCT00124397) | University of Southern Denmark | 2001-07-01 |
| Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy (NCT00358124) | Sanofi | 2001-01-01 |
| Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT) (NCT00032487) | VA Office of Research and Development | 2000-12-01 |
| The Role of Acute Combined PPAR Alpha and Gamma Stimulation on Insulin Action in Humans (NCT00179400) | Albert Einstein College of Medicine | 2000-12-01 |
| Pfizer/IVGTT/Ziprasidone/Olanzapine (NCT00205725) | Washington University School of Medicine | 2000-11-01 |
| Detection of Ischemia in Asymptomatic Diabetics (NCT00769275) | Yale University | 2000-08-01 |
| Janssen - Glucose Regulation/Risp/Olanz (NCT00205738) | Washington University School of Medicine | 2000-07-01 |
| Type 2 Diabetes Controlled Eating Experiment (NCT00198926) | Johns Hopkins Bloomberg School of Public Health | 2000-05-01 |
| Preferred Treatment of Type 1.5 Diabetes (NCT00194896) | University of Washington | 2000-02-01 |
| The Effect of Patients' Participation in Improving Diabetes Care (NCT00533494) | Soroka University Medical Center | 2000-01-01 |
| Diabetes Knowledge Assessment (NCT00198900) | Johns Hopkins Bloomberg School of Public Health | 2000-01-01 |
| Long-term of 10 Years Results of a Prospective Longitudinal Study (NCT01557972) | Nagaoka Red Cross Hospital | 1999-11-01 |
| Signaling Mechanisms and Vascular Function in Patients With Diabetes Mellitus (NCT00762671) | Brigham and Women's Hospital | 1999-05-01 |
| Signaling Mechanisms and Vascular Function in Diabetes Mellitus (NCT00761852) | Brigham and Women's Hospital | 1999-05-01 |
| Early Diabetes Intervention Program (NCT01470937) | Indiana University | 1998-02-01 |
| Optimal Dietary Fat Pattern to Prevent Cardiovascular Disease Among Type 2 Diabetes (NCT00467168) | Sun Yat-sen University | 1998-01-01 |
| Weight Trajectory in New Users of Sulfonylureas as Add on Therapy Next to Metformin. (NCT02133118) | Medical Research Foundation, The Netherlands | 1998-01-01 |
| The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial (NCT00375388) | Bethesda General Hospital, Hoogeveen | 1998-01-01 |
| Lipid, Glycemic, and Insulin Responses to Meals Rich in Different Fatty Acids (NCT00479791) | University of Texas Southwestern Medical Center | 1997-04-01 |
| Post-marketing Clinical Trial of KAD-1229 in Patients With Type 2 Diabetes Mellitus (NCT02154347) | Kissei Pharmaceutical Co., Ltd. | |
| Diacerein on Insulin Secretion in Diabetes (NCT01298882) | Coordinación de Investigación en Salud, Mexico | |
| Open Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide (NCT00334503) | Sanwa Kagaku Kenkyusho Co., Ltd. | |
| Diurnal Triglyceridemia in Relation to Alcohol Intake (NCT01786421) | Sint Franciscus Gasthuis | |
| Effects of Achieving Very Low LDL-Cholesterol After Treatment With Statins on Steroidogenesis and Cognition (NCT00522158) | Baskent University | |
| Effects of Rosiglitazone on Serum Ghrelin and Peptide YY Levels (NCT00522470) | Baskent University | |
| Double-Blind Study of Miglitol in Japanese With type2 Diabetes (NCT00380822) | Sanwa Kagaku Kenkyusho Co., Ltd. | |
| Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide (NCT00334399) | Sanwa Kagaku Kenkyusho Co., Ltd. | |
| Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus (NCT00532506) | Sanwa Kagaku Kenkyusho Co., Ltd. | |
| Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients (NCT00189774) | Astellas Pharma Inc | |
| Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin Treatment (NCT00213070) | Sanwa Kagaku Kenkyusho Co., Ltd. | |
| Effects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With Insulin (NCT00213122) | Sanwa Kagaku Kenkyusho Co., Ltd. | |
| Exercise Training Improves Coronary Endothelial Dysfunction in Diabetes Mellitus Type 2 and Coronary Artery Disease (NCT00693537) | Paracelsus Medical University | |
| Treatment Use of Generex Oral-lyn™ in Patients With Diabetes (NCT00948493) | Generex Biotechnology Corp. | |
| The Effects of Short-time High-intensity Interval Training on Tissue Glucose and Fat Metabolism in Healthy Subjects and Patients With Type 2 Diabetes (NCT01344928) | Turku University Hospital | |